NEXI - PATH ULTA and CAN are among pre market gainers

2023-12-01 08:31:39 ET

• Neximmune  ( NEXI ) +338% .
• Jeffs Brands  ( JFBR ) +64% Received Regulatory Approvals in Spain and The Netherlands to Commence Sales.
• ShiftPixy  ( PIXY ) +26% .
• Altimmune ( ALT ) +38% pulls back from twice-daily regime of weight-loss drug candidate.
• Biora Therapeutics  ( BIOR ) +29% clears Biora to begin Phase 1 testing of ulcerative colitis treatment.
• Sigma Additive Solutions  ( SASI ) +31% .
• Clearmind Medicine  ( CMND ) +22% .
• Elastic ( ESTC ) +18% Q2 earnings call reease
• Fenbo Holdings Limited ( FEBO ) +17% .
• UiPath ( PATH ) +15% .
• Samsara ( IOT ) +13% .
• Ulta Beauty  ( ULTA ) +11% .
• GigaCloud Technology  ( GCT ) +9% Q3 earnings call release
• Canaan  ( CAN ) +3% .
• Pagerduty  ( PD ) +6% Q3 earnings call release
• Taoping  ( TAOP ) +6% .
• Hongli Group ( HLP ) +6% .
• Soho House  ( SHCO ) +5% .

For further details see: